Company overview
Transgene is a clinical-stage biotechnology company developing virus-based immunotherapies, primarily for cancer treatment. Key offerings include TG4050, an individualized neoantigen therapeutic vaccine using MVA viral vector technology combined with AI-driven neoantigen prediction. These therapies target solid tumors like head and neck cancer to stimulate patient-specific immune responses and prevent relapse.
Transgene is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include transgene, viral immunotherapy, neoantigen vaccine, mva vector, cancer biotherapy.
Structured facts
- Website
- https://www.transgene.fr
- Markets served
- United States & Americas
- Keywords
- transgene, viral immunotherapy, neoantigen vaccine, mva vector, cancer biotherapy
Products & technologies
Therapeutic areas
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What are Transgene's main therapeutic capabilities?
- Transgene specializes in virus-based immunotherapies using myvac® MVA viral vector platform for individualized neoantigen vaccines like TG4050 targeting cancer neoantigens.
- What is the development stage of TG4050?
- TG4050 is in clinical evaluation for resected HPV-negative head and neck cancer, assessing relapse prevention post-surgery and adjuvant therapy in Phase 2 trials.
- What technologies power Transgene's products?
- Products leverage bioengineering, viral vectorization, AI/ML for neoantigen selection via partnerships like NEC, and digital transformation for oncology applications.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
